Share Search
Visit the Share Search
Diaceutics Accounts Summary
| Date of Accounts | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Standard | IFRS | IFRS | IFRS | IFRS | IFRS |
| Millions | Millions | Millions | Millions | Millions | |
| Income Statement | 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 |
| Revenue | 38.44 | 32.16 | 23.70 | 19.50 | 13.94 |
| Operating Profit / Loss | 0.04 | -2.46 | -3.02 | 0.57 | 0.55 |
| Net Interest | 0.26 | 0.55 | 0.58 | -0.01 | -0.09 |
| Pre Tax Profit | 0.30 | 1.91 | -2.44 | 0.56 | 0.46 |
| Post Tax Profit | 0.10 | -1.70 | -1.75 | 0.72 | 0.56 |
| Profit for the Period | 0.10 | -1.70 | -1.75 | 0.72 | 0.56 |
| Equity Holders of Parent Company | 0.10 | -1.70 | -1.75 | 0.72 | 0.56 |
| Minority Interests | n/a | n/a | n/a | n/a | n/a |
| Continuing EPS | |||||
| Earnings per Share (Basic) | 11.00p | -202.00p | -2.07p | 0.86p | 0.67p |
| Earnings per Share (Diluted) | 11.00p | -202.00p | -2.07p | 0.84p | 0.66p |
| Earnings per Share (Adjusted) | 11.00p | -202.00p | -2.07p | 0.86p | 0.67p |
| Continuing and Discontinued EPS | |||||
| Earnings per Share (Basic) | 11.00p | -202.00p | -2.07p | 0.86p | 0.67p |
| Earnings per Share (Diluted) | 11.00p | -202.00p | -2.07p | 0.84p | 0.66p |
| Earnings per Share (Adjusted) | 11.00p | -202.00p | -2.07p | 0.86p | 0.67p |
| Dividend per Share | n/ap | n/ap | n/ap | n/ap | n/ap |
| Millions | Millions | Millions | Millions | Millions | |
| Balance Sheet | 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 |
| Non-Current Assets | |||||
| Intangible Assets | 16.08 | 15.41 | 15.26 | 15.22 | 12.82 |
| Property, Plant and Equipment | 1.66 | 1.68 | 1.90 | 2.09 | 2.13 |
| Investments | n/a | n/a | n/a | n/a | n/a |
| Investment Properties | n/a | n/a | n/a | n/a | n/a |
| Other Financial Assets | n/a | n/a | n/a | n/a | n/a |
| Other Non-Current Assets | 2.90 | 2.00 | 1.14 | 0.05 | 0.00 |
| Total Non-Current Assets | 20.65 | 19.09 | 18.30 | 17.36 | 14.95 |
| Current Assets | |||||
| Inventories | n/a | n/a | n/a | n/a | n/a |
| Trade and Other Receivables | 21.26 | 16.04 | 11.37 | 11.06 | 10.39 |
| Cash at Bank and in Hand | 7.34 | 12.74 | 16.67 | 19.84 | 19.68 |
| Current Asset Investments | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 0.76 | 0.74 | n/a | n/a | n/a |
| Total Current Assets | 29.36 | 29.53 | 28.03 | 30.90 | 30.06 |
| Other Assets | n/a | n/a | n/a | n/a | n/a |
| Total Assets | 50.01 | 48.62 | 46.34 | 48.26 | 45.01 |
| Current Liabilities | |||||
| Borrowings | 0.27 | 0.15 | 0.15 | 0.12 | 0.28 |
| Other Current Liabilities | 8.28 | 7.61 | 4.24 | 3.63 | 2.36 |
| Total Current Liabilities | 8.55 | 7.76 | 4.38 | 3.75 | 2.63 |
| Net Current Assets | n/a | n/a | n/a | n/a | n/a |
| Non-Current Liabilities | |||||
| Borrowings | 0.88 | 0.91 | 1.06 | 1.21 | 1.28 |
| Provisions | 0.10 | 0.09 | 0.12 | 0.79 | 0.44 |
| Other Non-Current Liabilities | n/a | n/a | n/a | n/a | n/a |
| Total Non-Current Liabilities | 0.98 | 1.00 | 1.18 | 1.99 | 1.73 |
| Net Assets | 40.48 | 39.86 | 40.79 | 42.51 | 40.65 |
| Capital and Reserves | |||||
| Share Capital | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 |
| Share Premium Account | n/a | n/a | 37.13 | 37.13 | 36.86 |
| Other Reserves | -1.29 | -0.94 | -0.55 | -0.12 | -0.47 |
| Retained Earnings | 41.60 | 40.62 | 4.04 | 5.34 | 4.08 |
| Shareholders Funds | 40.48 | 39.86 | 40.79 | 42.51 | 40.65 |
| Minority Interests / Other Equity | n/a | n/a | n/a | n/a | n/a |
| Total Equity | 40.48 | 39.86 | 40.79 | 42.51 | 40.65 |
| 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 | |
| Operating Margin | 0.11% | -7.63% | -12.73% | 2.95% | 3.94% |
| Return on Capital Employed | 0.17% | 5.32% | -11.24% | 1.96% | 1.84% |
| Dividend Cover | n/a | n/a | n/a | n/a | n/a |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | 11.60 | n/a | n/a | 87.80 | 152.20 |
| PEG | n/a | n/a | n/a | 3.10 | n/a |
| Dividend per Share Growth | n/a% | n/a% | n/a% | n/a% | n/a% |
| Net Asset Value per Share | 28.72p | 28.77p | 30.06p | 32.14p | 32.77p |